Abiopharma

DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

New Form SCHEDULE 13G - ProMIS Neurosciences Inc. Filed: 2025-08-04 AccNo: 0001641172-25-022106 Size: 29 KB

New Form 4 - STRYKER CORP Filed: 2025-08-04 AccNo: 0001628280-25-037509 Size: 5 KB

New Form 3 - ProMIS Neurosciences Inc. Filed: 2025-08-04 AccNo: 0001641172-25-022100 Size: 13 KB

New Form SCHEDULE 13G - Celcuity Inc. Filed: 2025-08-04 AccNo: 0000950170-25-102193 Size: 10 KB

New Form SCHEDULE 13G/A - Celcuity Inc. Filed: 2025-08-04 AccNo: 0000950170-25-102185 Size: 10 KB

New Form 4 - BOSTON SCIENTIFIC CORP Filed: 2025-08-04 AccNo: 0001225208-25-006987 Size: 4 KB

New Form 4 - BOSTON SCIENTIFIC CORP Filed: 2025-08-04 AccNo: 0001225208-25-006986 Size: 9 KB

New Form 4 - BOSTON SCIENTIFIC CORP Filed: 2025-08-04 AccNo: 0001225208-25-006988 Size: 8 KB

New Form 4 - BOSTON SCIENTIFIC CORP Filed: 2025-08-04 AccNo: 0001225208-25-006985 Size: 21 KB

ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit

New Form 4 - HERON THERAPEUTICS, INC. /DE/ Filed: 2025-08-04 AccNo: 0000950170-25-102161 Size: 7 KB

New Form 4 - HERON THERAPEUTICS, INC. /DE/ Filed: 2025-08-04 AccNo: 0000950170-25-102158 Size: 7 KB

Nuwellis Stockholders Approve All Proposals at Special Meeting

New Form 4 - HERON THERAPEUTICS, INC. /DE/ Filed: 2025-08-04 AccNo: 0000950170-25-102150 Size: 7 KB